|
2J3N
X-ray structure of human thioredoxin reductase 1
Deposited 2006-08-22
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–499(499 aa)
Chain B
1–499(499 aa)
|
Not recorded
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE × 2
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
R-free 0.287
|
|
2J3N
X-ray structure of human thioredoxin reductase 1
Deposited 2006-08-22
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–499(499 aa)
Chain D
1–499(499 aa)
|
Not recorded
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE × 2
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
R-free 0.287
|
|
2J3N
X-ray structure of human thioredoxin reductase 1
Deposited 2006-08-22
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain E
1–499(499 aa)
Chain F
1–499(499 aa)
|
Not recorded
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE × 2
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
R-free 0.287
|
|
2ZZ0
Crystal structure of human thioredoxin reductase I (SeCys 498 Cys)
Deposited 2009-02-02
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
150–649(500 aa)
Fragment:residues (-13)-499
Chain B
150–649(500 aa)
Fragment:residues (-13)-499
|
Mutation:SeCys498Cys
Mutation:SeCys498Cys
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;5% PEG 3350, 0.005M magnesium Sulfate, 0.05M MES, pH 6.0, 20% 1,6 Hexanediol (0.001mL), VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.80 Å
R-free 0.277
|
|
2ZZ0
Crystal structure of human thioredoxin reductase I (SeCys 498 Cys)
Deposited 2009-02-02
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
150–649(500 aa)
Fragment:residues (-13)-499
Chain D
150–649(500 aa)
Fragment:residues (-13)-499
|
Mutation:SeCys498Cys
Mutation:SeCys498Cys
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;5% PEG 3350, 0.005M magnesium Sulfate, 0.05M MES, pH 6.0, 20% 1,6 Hexanediol (0.001mL), VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.80 Å
R-free 0.277
|
|
2ZZB
Crystal structure of human thioredoxin reductase I and terpyridine platinum(II)
Deposited 2009-02-09
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
150–649(500 aa)
Fragment:residues (-13)-499
Chain B
150–649(500 aa)
Fragment:residues (-13)-499
|
Mutation:SeCys498Cys
Mutation:SeCys498Cys
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
SO4 SULFATE ION × 2
TPT 2,2':6',2''-TERPYRIDINE PLATINUM(II) Chloride × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;5% PEG 3350, 0.005M magnesium Sulfate, 0.05M MES, pH 6.0, additive: 20% 1,6 Hexanediol (0.001mL), VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.20 Å
R-free 0.305
|
|
2ZZB
Crystal structure of human thioredoxin reductase I and terpyridine platinum(II)
Deposited 2009-02-09
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
150–649(500 aa)
Fragment:residues (-13)-499
Chain D
150–649(500 aa)
Fragment:residues (-13)-499
|
Mutation:SeCys498Cys
Mutation:SeCys498Cys
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
SO4 SULFATE ION × 2
TPT 2,2':6',2''-TERPYRIDINE PLATINUM(II) Chloride × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;5% PEG 3350, 0.005M magnesium Sulfate, 0.05M MES, pH 6.0, additive: 20% 1,6 Hexanediol (0.001mL), VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.20 Å
R-free 0.305
|
|
2ZZC
Crystal structure of NADP(H):human thioredoxin reductase I
Deposited 2009-02-09
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
150–649(500 aa)
Fragment:residues (-13)-499
Chain B
150–649(500 aa)
Fragment:residues (-13)-499
|
Mutation:SeCys498Cys
Mutation:SeCys498Cys
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;5% PEG 3350, 0.005M Magnesium Sulfate, 0.05M MES, pH 6.0, additive: 20% 1,6 Hexanediol (0.001mL), VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.60 Å
R-free 0.260
|
|
2ZZC
Crystal structure of NADP(H):human thioredoxin reductase I
Deposited 2009-02-09
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
150–649(500 aa)
Fragment:residues (-13)-499
Chain D
150–649(500 aa)
Fragment:residues (-13)-499
|
Mutation:SeCys498Cys
Mutation:SeCys498Cys
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;5% PEG 3350, 0.005M Magnesium Sulfate, 0.05M MES, pH 6.0, additive: 20% 1,6 Hexanediol (0.001mL), VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.60 Å
R-free 0.260
|
|
3QFA
Crystal structure of the human thioredoxin reductase-thioredoxin complex
Deposited 2011-01-21
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–499(499 aa)
Chain B
1–499(499 aa)
|
Mutation:C497S, U498C
Mutation:C497S, U498C
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
GOL GLYCEROL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;297.15 K;15% PEG 6000, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 297.15 K
|
Resolution 2.20 Å
R-free 0.283
|
|
3QFB
Crystal structure of the human thioredoxin reductase-thioredoxin complex
Deposited 2011-01-21
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–499(499 aa)
Chain B
1–499(499 aa)
|
Mutation:C497S, U498C
Mutation:C497S, U498C
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
GOL GLYCEROL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.6;297.15 K;15% PEG 4000, pH 7.6, VAPOR DIFFUSION, HANGING DROP, temperature 297.15K
|
Resolution 2.60 Å
R-free 0.297
|
|
7X1R
Cryo-EM structure of human thioredoxin reductase bound by Au
Deposited 2022-02-24
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
152–649(498 aa)
Chain B
152–649(498 aa)
|
Not recorded
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
AU GOLD ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.90 Å
|
|
9UIN
Human thioredoxin reductase 1 (SeCys 498 Cys) with Cu(I)
Deposited 2025-04-15
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
151–649(499 aa)
Chain B
151–649(499 aa)
|
Mutation:SEC498C
Mutation:SEC498C
|
TXP 1,4,5,6-TETRAHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE × 2
FAD FLAVIN-ADENINE DINUCLEOTIDE × 2
CU COPPER (II) ION × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.03 Å
|